IRF1 and central nervous system cancer: Higher expression of p-STAT1 was shown to be associated with poor prognosis in glioma and depletion of IRF1/STAT1 signaling has been reported to increase the efficacy of anti-VEGF (bevacizumab) therapy in a glioma xenograft model44, 45, 46.